Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

  1. Talukder, R.
  2. Makrakis, D.
  3. Lin, G.I.
  4. Diamantopoulos, L.N.
  5. Dawsey, S.
  6. Gupta, S.
  7. Carril-Ajuria, L.
  8. Castellano, D.
  9. de Kouchkovsky, I.
  10. Jindal, T.
  11. Koshkin, V.S.
  12. Park, J.J.
  13. Alva, A.
  14. Bilen, M.A.
  15. Stewart, T.F.
  16. McKay, R.R.
  17. Tripathi, N.
  18. Agarwal, N.
  19. Vather-Wu, N.
  20. Zakharia, Y.
  21. Morales-Barrera, R.
  22. Devitt, M.E.
  23. Cortellini, A.
  24. Fulgenzi, C.A.M.
  25. Pinato, D.J.
  26. Nelson, A.
  27. Hoimes, C.J.
  28. Gupta, K.
  29. Gartrell, B.A.
  30. Sankin, A.
  31. Tripathi, A.
  32. Zakopoulou, R.
  33. Bamias, A.
  34. Murgic, J.
  35. Fröbe, A.
  36. Rodriguez-Vida, A.
  37. Drakaki, A.
  38. Liu, S.
  39. Lu, E.
  40. Kumar, V.
  41. Lorenzo, G.D.
  42. Joshi, M.
  43. Isaacsson-Velho, P.
  44. Buznego, L.A.
  45. Duran, I.
  46. Moses, M.
  47. Barata, P.
  48. Sonpavde, G.
  49. Wright, J.L.
  50. Yu, E.Y.
  51. Montgomery, R.B.
  52. Hsieh, A.C.
  53. Grivas, P.
  54. Khaki, A.R.
  55. Mostra tots els autors/es +
Revista:
Clinical Genitourinary Cancer

ISSN: 1938-0682,  1558-7673

Any de publicació: 2022

Volum: 20

Número: 6

Pàgines: 558-567

Tipus: Article

DOI: 10.1016/J.CLGC.2022.08.006 GOOGLE SCHOLAR
Font de les dades: Scopus